[18F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Corticobasal syndrome (CBS) is a phenotypic manifestation of diverse pathologies, including Alzheimer’s disease and 4-repeat tauopathies. Predicting pathology in CBS is unreliable and, hence, molecular neuroimaging may prove to be useful. The aim of this study was to assess regional patterns of uptake on [18F] AV-1451 PET in CBS and determine whether patterns of uptake differ according to beta-amyloid deposition or differing clinical presentations. Fourteen patients meeting criteria for CBS underwent Pittsburgh Compound B (PiB) and [18F] AV-1451 PET. Seven patients presented as CBS and seven presented with apraxia of speech (AOS) and later evolved into CBS. A global PiB summary was calculated and used to classify patients as PiB (−) or PiB (+). AV-1451 uptake was calculated in fourteen regions-of-interest, with values divided by uptake in cerebellar crus grey matter to generate standard uptake value ratios. AV-1451 uptake was considered elevated if it fell above the 95th percentile from a group of 476 cognitively unimpaired normal controls. Six of the 14 CBS patients (43%) were PiB (+), with three of these patients showing strikingly elevated AV-1451 uptake across many cortical regions. Of the eight PiB (−) patients, only those with AOS showed elevated AV-1451 uptake in supplementary motor area and precentral cortex compared to controls. No region of elevated AV-1451 uptake were observed in PiB (−) typical CBS patients without AOS. These results suggest that regional [18F] AV-1451 is variable in CBS and depends on the presence of beta-amyloid as well as clinical presentation such as AOS. PiB (+) CBS does not necessarily reflect underlying Alzheimer’s disease; however, the possibility some of these patients will evolve into Alzheimer’s disease over time cannot be excluded.

Original languageEnglish (US)
Pages (from-to)1079-1088
Number of pages10
JournalJournal of Neurology
Issue number5
StatePublished - May 1 2018


  • Alzheimer’s disease
  • Beta-amyloid
  • Corticobasal syndrome
  • Positron emission tomography
  • Tau

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology


Dive into the research topics of '[18F] AV-1451 uptake in corticobasal syndrome: the influence of beta-amyloid and clinical presentation'. Together they form a unique fingerprint.

Cite this